Oral sirolimus for prevention of recurrent infrainguinal arterial obstructions after surgical and endovascular revascularizations.
第一作者:
H,Keo
第一单位:
Swiss Cardiovascular Center, Division of Angiology, Inselspital, University Hospital and University of Bern, Switzerland. keo.hakhong@insel.ch
作者:
医学主题词
投药, 口服(Administration, Oral);老年人(Aged);血管成形术, 气囊(Angioplasty, Balloon);心血管药物(Cardiovascular Agents);缩窄, 病理性(Constriction, Pathologic);女(雌)性(Female);人类(Humans);缺血(Ischemia);下肢(Lower Extremity);男(雄)性(Male);中年人(Middle Aged);外周血管疾病(Peripheral Vascular Diseases);再手术(Reoperation);隐静脉(Saphenous Vein);二级预防(Secondary Prevention);西罗莫司(Sirolimus);血栓切除术(Thrombectomy);治疗失败(Treatment Failure);血管外科手术(Vascular Surgical Procedures)
DOI
10.1024/0301-1526.37.3.285
PMID
18690598
发布时间
2014-11-20
- 浏览10
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



